Last $195.54 USD
Change Today +0.24 / 0.12%
Volume 723.8K
As of 8:04 PM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

mckesson corp (MCK) Snapshot

Open
$195.30
Previous Close
$195.30
Day High
$196.18
Day Low
$193.95
52 Week High
09/8/14 - $200.00
52 Week Low
09/24/13 - $127.45
Market Cap
45.3B
Average Volume 10 Days
890.5K
EPS TTM
$6.79
Shares Outstanding
231.6M
EX-Date
08/28/14
P/E TM
28.8x
Dividend
$0.96
Dividend Yield
0.49%
Current Stock Chart for MCKESSON CORP (MCK)

mckesson corp (MCK) Details

McKesson Corporation delivers pharmaceuticals, medical supplies, and health care information technologies to the healthcare industry in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes ethical and proprietary drugs and equipment, and health and beauty care products. This segment also provides specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers; and practice management, technology, clinical support, and business solutions to oncology and other specialty practices operating in the community setting. In addition, this segment offers medical-surgical supply distribution, equipment, logistics, and other services to healthcare providers through a network of distribution centers in the United States; sells financial, operational, and clinical solutions for pharmacies; and provides consulting, outsourcing, and other services. The McKesson Technology Solutions segment delivers enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions; and connectivity, outsourcing, and other services, such as remote hosting and managed services to healthcare organizations. This segment also offers InterQual clinical criteria solution, claims payment solutions, and network performance tools. This segment’s customers include hospitals, physicians, homecare providers, retail pharmacies, and payers. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.

71,400 Employees
Last Reported Date: 05/14/14
Founded in 1833

mckesson corp (MCK) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $1.7M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $2.0M
Executive Vice President and Group President
Total Annual Compensation: $1.1M
Executive Vice President and Group President
Total Annual Compensation: $684.0K
Principal Accounting Officer, Vice President ...
Total Annual Compensation: $623.1K
Compensation as of Fiscal Year 2014.

mckesson corp (MCK) Key Developments

Citizens Medical Center Chooses McKesson Business Performance Services to Optimize Revenue Cycle Management

McKesson Business Performance Services has been selected to optimize revenue cycle management for Citizens Medical Professional, the employed physician group of Citizens Medical Center, a 344-bed acute care hospital in Victoria, Texas. McKesson will take responsibility for creating a unified billing and reporting platform to support the 19 primary care physicians and specialists of Citizens Medical Professional. McKesson will provide coding, claims, billing, denial management and collections services. The agreement is expected to improve financial performance and facilitate comprehensive management reporting.

Prince George's County Fire/EMS Department Selects McKesson Business Performance Services to Provide an End-To-End, Technology-Based Revenue Cycle Solution

Prince George's County Fire/EMS Department has selected McKesson Business Performance Services (McKesson) to provide an end-to-end, technology-based revenue cycle solution for enhanced collections, better operational reporting and improved regulatory compliance. McKesson will be responsible for coding, claims and denial management, and also will oversee the department's transition to a new electronic patient care reporting (EPCR) system. The advanced platform is capable of conveying incident data to the state of Maryland, and will connect with 100 mobile tablets, or Toughbooks(R), supplied by McKesson for capturing patient care services information in the field.

McKesson Corporation Resolves to Pay $18 Million Against Allegations of Improperly Set Temperature Monitors Used in Shipping Vaccines

McKesson Corporation has agreed to pay $18 million to resolve allegations that it improperly set temperature monitors used in shipping vaccines under its contract with the Centers for Disease Control and Prevention (CDC), the Justice Department. If a contractor does not adhere to the terms it negotiated, its conduct not only hurts taxpayers but also could jeopardize the integrity of products, like vaccines, that Americans count on to be safe. The government alleged that McKesson failed to comply with the shipping and handling requirements of its vaccine distribution contract with the CDC. Under the contract, McKesson provided distribution services, receiving vaccines purchased by the government from manufacturers and then distributing the vaccines to health care providers. The government alleged that the contract required McKesson to ensure that during shipping, the vaccines were maintained at proper temperatures by, among other things, including electronic temperature monitors set to detect when the air temperature in the box reached two degrees Celsius and below or eight degrees Celsius and above. The government alleged that, from approximately April 2007 to November 2007, McKesson failed to set the monitors to the appropriate range, and as a result, knowingly submitted false claims to the CDC for shipping and handling services that did not satisfy its contractual obligations. According to the CDC, redundant measures were and are used to ensure vaccines are kept at appropriate temperatures during shipping. The most important of these were validated packing procedures used to maintain proper vaccine temperatures. Temperature monitors provided a secondary safeguard. The allegations resolved by settlement were originally raised in a lawsuit filed against McKesson by Terrell Fox, a former finance director at McKesson Specialty Distribution LLC, under the qui tam, or whistleblower, provisions of the False Claims Act, which allow private citizens with knowledge of false claims to bring civil actions on behalf of the government and to share in any recovery. Foxs share of the settlement has not been determined. This settlement illustrates the governments emphasis on combating health care fraud and marks another achievement for the Health Care Fraud Prevention and Enforcement Action Team (HEAT) initiative, which was announced in May 2009 by the Attorney General and the Secretary of Health and Human Services. The partnership between the two departments has focused efforts to reduce and prevent Medicare and Medicaid financial fraud through enhanced cooperation. One of the most powerful tools in this effort is the False Claims Act. Since January 2009, the Justice Department has recovered a total of more than $20.2 billion through False Claims Act cases, with more than $14 billion of that amount recovered in cases involving fraud against federal health care programs. The case was handled by the Civil Divisions Commercial Litigation Branch and the U.S. Attorneys Office for the Middle District of Tennessee, with assistance from HHS-OIG and Office of General Counsel. The claims settled by this agreement are allegations only, and there has been no determination of liability.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MCK:US $195.54 USD +0.24

MCK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AmerisourceBergen Corp $76.53 USD -0.58
Cardinal Health Inc $74.96 USD -0.59
Express Scripts Holding Co $73.93 USD -0.11
UnitedHealth Group Inc $86.99 USD -0.17
Walgreen Co $63.73 USD +0.09
View Industry Companies
 

Industry Analysis

MCK

Industry Average

Valuation MCK Industry Range
Price/Earnings 33.9x
Price/Sales 0.3x
Price/Book 5.0x
Price/Cash Flow 36.4x
TEV/Sales 0.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MCKESSON CORP, please visit www.mckesson.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.